Vitamin e supplement (DrugBank: Vitamin E)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 317 | Trifunctional protein deficiency | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00840112 (ClinicalTrials.gov) | July 2010 | 9/2/2009 | Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy | Vitamin E Treatment for LCHAD Associated Neuropathy | Peripheral Neuropathy;Mitochondrial Trifunctional Protein Deficiency | Dietary Supplement: Vitamin E supplement | Oregon Health and Science University | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Oregon State University | Terminated | 7 Years | N/A | Both | 1 | N/A | United States |